The influence of vascular risk factors on cognitive function in early Parkinson's disease M Doiron, M Langlois, N Dupré, M Simard International Journal of Geriatric Psychiatry 33 (2), 288-297, 2018 | 30 | 2018 |
Effects of antiparkinson medication on cognition in Parkinson’s disease: a systematic review MA Roy, M Doiron, J Talon-Croteau, N Dupré, M Simard Canadian Journal of Neurological Sciences 45 (4), 375-404, 2018 | 29 | 2018 |
Smoking history is associated to cognitive impairment in Parkinson's disease M Doiron, N Dupré, M Langlois, P Provencher, M Simard Aging & mental health 21 (3), 322-326, 2017 | 21 | 2017 |
A cognitive prosthesis for complex decision-making S Tremblay, JF Gagnon, D Lafond, HM Hodgetts, M Doiron, PP Jeuniaux Applied ergonomics 58, 349-360, 2017 | 17 | 2017 |
Idiopathic Parkinson's disease, vascular risk factors and cognition: A critical review M Doiron, M Simard Neurodegeneration, 2012 | 6 | 2012 |
Goal management training® home-based approach for mild cognitive impairment in Parkinson’s disease: a multiple baseline case report A Giguère-Rancourt, M Plourde, M Doiron, M Langlois, N Dupré, ... Neurocase 24 (5-6), 276-286, 2018 | 5 | 2018 |